STI testing is recommended annually for all sexually active people. Those with new or multiple partners should test every 3 months. Testing is free at NHS sexual health clinics and from online services (SH:24, SHGM). You do not need symptoms to be tested — most STIs cause no symptoms. A full STI screen covers chlamydia, gonorrhoea, syphilis, HIV, hepatitis B, and hepatitis C. Specific sites tested (urine, swabs, blood) depend on your sexual practices. Results are usually available within 1–2 weeks. Positive results trigger automatic partner notification advice.

Not all STIs are curable, but all are treatable. Bacterial STIs — chlamydia, gonorrhoea, and syphilis — are fully curable with antibiotics when diagnosed promptly. Viral STIs — HIV, herpes, HPV, and hepatitis B — cannot be cured but can be effectively managed. HIV is controlled with ART to the point of undetectability. Herpes is managed with antivirals that suppress outbreaks. HPV often clears naturally within 1–2 years in people with healthy immune systems. Genital warts can be treated and removed, though the underlying HPV virus may persist. The key message: all STIs are manageable with prompt diagnosis and treatment.

Without treatment, chlamydia can persist silently for months or years, causing progressive damage to the reproductive tract. In women, untreated chlamydia causes pelvic inflammatory disease (PID) in 10–15% of cases, leading to tubal factor infertility, chronic pelvic pain, and ectopic pregnancy risk increased 6–10-fold. In men, chlamydia causes epididymo-orchitis, which can impair sperm production and quality. Reactive arthritis (formerly Reiter's syndrome) — involving joint inflammation, eye inflammation, and urethritis — is a rare but recognised complication. These complications are entirely preventable with prompt diagnosis and a simple 7-day course of doxycycline.

Gonorrhoea is increasingly difficult to treat due to rising antibiotic resistance. The current UK first-line treatment is a single intramuscular injection of ceftriaxone 1g. A test of cure is required 2 weeks later to confirm eradication. Azithromycin is no longer recommended routinely due to resistance. Multidrug-resistant gonorrhoea has been identified in multiple countries, including the UK. If you have been treated for gonorrhoea and symptoms persist, return to the clinic immediately — do not take additional antibiotics without guidance. Treatment of all recent sexual partners is essential to prevent reinfection.

HPV vaccination is highly effective before first sexual contact but still provides meaningful protection after sexual debut. The NHS offers Gardasil 9 to all children aged 12–13 regardless of gender. Catch-up vaccination is available free up to age 25 for women and men who have not been vaccinated. MSM can receive free vaccination at sexual health clinics up to age 45. For people already exposed to HPV, the vaccine still protects against strains they have not yet encountered. HPV vaccination combined with regular cervical screening has the potential to virtually eliminate cervical cancer in the UK.

Yes. HIV is now a manageable chronic condition, not a death sentence. With antiretroviral therapy (ART), people with HIV can live long, healthy lives with a normal life expectancy. ART suppresses the virus to undetectable levels in the blood, meaning it cannot be transmitted sexually (Undetectable = Untransmittable, or U=U). Most people on modern ART take a single tablet daily and experience minimal side effects. HIV does not prevent you from having children, working, or having a fulfilling life. In the UK, HIV care is excellent and free on the NHS. The biggest barrier to good outcomes is late diagnosis — testing early is life-saving.

PEP (post-exposure prophylaxis) is a 28-day course of antiretroviral drugs that prevents HIV infection after a potential exposure. It must be started within 72 hours — the sooner the better. PEP is available from A&E departments, sexual health clinics, and some GUM clinics 24/7. It is free on the NHS for NHS patients. PEP is not a substitute for PrEP or condoms and should be used only in genuine emergencies (unprotected sex with a known HIV-positive person not on suppressive ART, condom failure, sexual assault, or needlestick). After completing PEP, an HIV test at 45 days and 3 months confirms whether infection was prevented.

PE affects approximately 20–30% of men at some point — making it the most common male sexual dysfunction. Many men suffer in silence due to embarrassment, assuming it is shameful or untreatable. In reality, PE is a well-recognised medical condition with highly effective treatments. Dapoxetine (a short-acting SSRI licensed specifically for PE) can more than triple ejaculatory latency time in clinical trials. Behavioural techniques (stop-start, squeeze) are effective for lifelong PE. Combining medication with psychological or couples therapy produces the best outcomes. Most men with PE who seek treatment experience significant improvement.